Cura Wealth Advisors’s AbbVie ABBV Stock Holding History

Cura Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.9M	Sell	289,872 -3,111	-1%	-$669K	31.14%	1
2026 Q1	$63.7M	Buy	292,983 +11,157	+4%	+$2.47M	28.52%	1
2025 Q4	$64.4M	Sell	281,826 -2,156	-0.8%	-$491K	24.41%	1
2025 Q3	$65.8M	Sell	283,982 -28,493	-9%	-$5.8M	25.13%	1
2025 Q2	$58M	Buy	312,475 +13,960	+5%	+$2.59M	23.19%	1
2025 Q1	$62.5M	Sell	298,515 -1,137	-0.4%	-$221K	25.31%	1
2024 Q4	$53.2M	Buy	+299,652	New	+$55.1M	23.55%	1

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cura Wealth Advisors's ABBV Position: Q2 2026 in Review

Cura Wealth Advisors reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $669K and leaving 289,872 shares worth $72.9M. The position accounts for 31.14% of the portfolio, ranked #1.

Cura Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cura Wealth Advisors held 289,872 shares of AbbVie worth $72.9M as of Q2 2026.
Cura Wealth Advisors sold 3,111 AbbVie shares in Q2 2026, an estimated $669K.
AbbVie made up 31.14% of Cura Wealth Advisors's portfolio in Q2 2026, its #1 holding.
Cura Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cura Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.